| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,653,300 | 1,634,300 | 1,601,300 | 1,718,200 | | Cost of Revenue | 538,700 | 536,300 | 515,500 | 556,000 | | | Gross Profit | 1,114,600 | 1,098,000 | 1,085,800 | 1,162,200 | | | Operating Expenses | | Research Development | 83,700 | 82,600 | 80,400 | 99,800 | | Selling General and Administrative | 643,900 | 617,100 | 616,600 | 647,600 | | Non Recurring | 48,900 | 8,500 | 9,600 | 4,500 | | Others | 26,700 |
-
|
-
| 40,000 | | | | Total Operating Expenses | 803,200 |
-
|
-
| 791,900 | | | | Operating Income or Loss | 311,400 | 389,800 | 379,200 | 370,300 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,000 | 10,200 | 7,200 | 9,800 | | Earnings Before Interest And Taxes | 314,400 | 400,000 | 386,400 | 380,100 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 314,400 | 400,000 | 386,400 | 380,100 | | Income Tax Expense | 85,400 | 108,700 | 105,300 | 102,400 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 229,000 | 291,300 | 281,100 | 277,700 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 229,000 | 291,300 | 281,100 | 277,700 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $229,000 | $291,300 | $281,100 | $277,700 |
|
0.18% Nasdaq 
0.23%
Income Statement
